Vaccination strategies for the prevention of meningococcal disease
Routine prophylactic vaccination and mass vaccination strategies have been used to control both endemic and epidemic disease caused by Neisseria meningitidis globally. This review discusses real-world examples of these vaccination strategies, their implementation, and outcomes of these efforts, with...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2018-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_92f2aff936f3494e9f0c7b8ebe03e4c9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Scott Vuocolo |e author |
| 700 | 1 | 0 | |a Paul Balmer |e author |
| 700 | 1 | 0 | |a William C. Gruber |e author |
| 700 | 1 | 0 | |a Kathrin U. Jansen |e author |
| 700 | 1 | 0 | |a Annaliesa S. Anderson |e author |
| 700 | 1 | 0 | |a John L. Perez |e author |
| 700 | 1 | 0 | |a Laura J. York |e author |
| 245 | 0 | 0 | |a Vaccination strategies for the prevention of meningococcal disease |
| 260 | |b Taylor & Francis Group, |c 2018-05-01T00:00:00Z. | ||
| 500 | |a 2164-5515 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 10.1080/21645515.2018.1451287 | ||
| 520 | |a Routine prophylactic vaccination and mass vaccination strategies have been used to control both endemic and epidemic disease caused by Neisseria meningitidis globally. This review discusses real-world examples of these vaccination strategies, their implementation, and outcomes of these efforts, with the overall goal of providing insights on how to achieve optimal control of meningococcal disease through vaccination in varied settings. Tailoring immunization programs to fit the needs of the target population has the potential to optimally reduce disease incidence. | ||
| 546 | |a EN | ||
| 690 | |a neisseria meningitidis | ||
| 690 | |a vaccination strategies | ||
| 690 | |a epidemics | ||
| 690 | |a epidemiology | ||
| 690 | |a prophylaxis | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 14, Iss 5, Pp 1203-1215 (2018) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/21645515.2018.1451287 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/92f2aff936f3494e9f0c7b8ebe03e4c9 |z Connect to this object online. |